Immunology and Microbiology
Arachidonic Acid Metabolism
12%
B Cell
50%
Bone Development
12%
Bone Remodeling
62%
Cancer Cell
66%
CD86
12%
Cell Infiltration
50%
Cell Killing
8%
Cell Migration
16%
Cell Proliferation
16%
Circulating Tumor Cell
41%
Claudin
50%
Coculture
16%
Cyclophosphamide
25%
Granulocyte
50%
Hematopoiesis
25%
Hematopoietic Cell
12%
Homeostasis
12%
Immune Checkpoint Blockade
12%
Immune Response
12%
Immunity
25%
Immunomodulation
12%
Immunosuppression
50%
Immunosuppressive Drug
37%
Immunosurveillance
50%
Immunotherapy
25%
Knockout Mouse
12%
Lineage
33%
Lipid Storage
12%
Low Drug Dose
12%
Macrophage Migration Inhibition
50%
Mouse Model
12%
Myeloid
12%
Natural Killer Cell
50%
Neural Cell Adhesion Molecule
16%
Neutrophil
50%
Osteoprogenitor Cell
50%
Overall Survival
12%
P53
12%
Programmed Death 1 Receptor
25%
RNA Sequence
25%
Syngenic
12%
T Cell
50%
T-Helper Cell
12%
Tertiary Lymphoid Structure
12%
Tumor Cell
87%
Tumor Immunity
25%
Tumor Volume
12%
Tumor-Associated Macrophage
50%
Tumor-Infiltrating Lymphocytes
12%
Keyphrases
Anti-programmed Cell Death Protein 1
25%
Anti-tumor Response
12%
Antigen-presenting
12%
Arachidonic Acid
50%
B Cell Infiltration
50%
B Cells
25%
B220
12%
Breast Cancer Model
12%
CD4 T Cells
12%
CD86
12%
Cell-to-cell
50%
Chemotherapy
62%
Chemotherapy Treatment
25%
Claudin-low
25%
Claudin-low Breast Cancer
25%
Combination Immunotherapy
12%
CSF1R
25%
CSF1R Inhibitor
12%
Cyclophosphamide
12%
Cytolytic T Cells
12%
Differential Treatment
12%
High-dimensional Imaging
12%
Human Patients
25%
Immune Response
12%
Immune Suppression
50%
Immune Therapy
50%
Lineage Depletion
12%
Lipids
25%
Lung Metastasis
12%
Macrophages
50%
Murine Mammary Tumors
12%
Murine Tumors
12%
Neutrophils
50%
Overall Survival
12%
Pharmacological Inhibitors
25%
Polyclonal Metastasis
50%
Single-cell RNA Sequencing (scRNA-seq)
25%
Spatial Localization
12%
T Cells
50%
T Helper Cells
25%
Tertiary Lymphoid Structures
12%
Therapy Resistance
50%
Treatment Regimen
12%
Treatment Response
25%
Triple-negative Breast Cancer
100%
Triple-negative Breast Cancer Cells
25%
Tumor
50%
Tumor Immune Microenvironment
12%
Tumor Microenvironment
12%
Tumor-associated Macrophages
50%
Medicine and Dentistry
B Cell
50%
Bone Development
10%
Bone Marrow Stromal Cell
50%
Bone Metastasis
70%
Bone Remodeling
60%
Breast Cancer
37%
Breast Tumor
12%
Cancer
20%
Cancer Cell
26%
Cancer Model
12%
Cell Migration
16%
Cell Proliferation
16%
Cellular Infiltration
50%
Claudin
50%
Combination Therapy
12%
Cyclophosphamide
25%
Hematopoiesis
20%
Homeostasis
10%
Imaging Technique
12%
Immune Response
12%
Immunomodulation
10%
Immunosuppressive Drug
12%
Immunotherapy
12%
In Vitro
16%
Low Drug Dose
12%
Lung Metastasis
12%
Macrophage
50%
Macrophage Migration Inhibition
50%
Metastatic Carcinoma
100%
Neoplasm
50%
Nerve Cell Adhesion Molecule
16%
Osteoplasty
60%
Overall Survival
12%
Pathologic Fracture
16%
Primary Tumor
10%
Protein P53
12%
RNA Sequence
12%
Stromal Cell
16%
T Cell
50%
T-Helper Cell
12%
Tertiary Lymphoid Structure
12%
Treatment Response
25%
Triple Negative Breast Cancer
50%
Tumor Immune Microenvironment
12%
Tumor Infiltrating Lymphocyte
12%
Tumor Microenvironment
12%
Tumor Model
12%
Tumor Regression
12%
